Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements [Yahoo! Finance]
Assertio Holdings, Inc. (ASRT)
Last assertio holdings, inc. earnings: 3/9 04:02 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
has received confirmation from The Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with all applicable listing requirements. As of January 12, 2026, Nasdaq has determined that Assertio has regained compliance with the Minimum Bid Price Rule, which requires the Company's common stock maintains a minimum bid price of $1.00 per share for a minimum of ten consecutive days, and that the matter is now closed. Mark Reisenauer, Chief Executive Officer of Assertio: "We are pleased to have regained compliance with applicable listing requirements. Importantly, we accomplished this efficiently with the successful completion of our December 2025 reverse stock-split, while preserving capital allocation flexibility." About Assertio Assertio is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients' needs. Our focus is on supporting patients by marketing products in oncology, neurology, and pa
Show less
Read more
Impact Snapshot
Event Time:
ASRT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ASRT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ASRT alerts
High impacting Assertio Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
ASRT
News
- Assertio regains Nasdaq compliance after bid price recovery [Seeking Alpha]Seeking Alpha
- Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing RequirementsBusiness Wire
- How Recent Valuation Reset And Leadership Changes Are Reframing The Assertio Holdings (ASRT) Story [Yahoo! Finance]Yahoo! Finance
- Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical TrialBusiness Wire
- Assertio (NASDAQ:ASRT) had its "buy" rating reaffirmed by analysts at HC Wainwright.MarketBeat
ASRT
Earnings
- 11/10/25 - Beat
ASRT
Analyst Actions
- 1/5/26 - HC Wainwright
ASRT
Sec Filings
- 1/12/26 - Form 8-K
- 12/22/25 - Form 8-K
- 11/21/25 - Form 8-K
- ASRT's page on the SEC website